| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 160,462 | 190,574 | ||
| Restricted cash equivalents | - | 2,413 | ||
| Marketable securities | 10,000 | 9,991 | ||
| Prepaid expenses | 747 | 1,500 | ||
| Other current assets | 1,277 | 449 | ||
| Total current assets | 172,486 | 204,927 | ||
| Restricted cash | 168 | 0 | ||
| Property and equipment, net | 271 | 0 | ||
| Operating lease right-of-use assets | 3,043 | 24 | ||
| Other assets | 269 | 420 | ||
| Total assets | 176,237 | 205,371 | ||
| Accounts payable | 885 | 669 | ||
| Accrued liabilities | 17,702 | 58,104 | ||
| Operating lease liabilities | 252 | 0 | ||
| Total current liabilities | 18,839 | 58,773 | ||
| Operating lease liabilities, less current portion | 2,807 | 0 | ||
| Warrant liabilities | 2,380,078 | 1,652,298 | ||
| Total liabilities | 2,401,724 | 1,711,071 | ||
| Common stock, 0.0001 par value 800,000,000 and 400,000,000 shares authorized as of september 30, 2025 and december 31, 2024, respectively 9,026,922 and 6,238,799 shares issued and outstanding as of september 30, 2025 and december 31, 2024, respectively | 15 | 13 | ||
| Additional paid-in capital | 650,319 | 557,422 | ||
| Accumulated other comprehensive income | 12 | 14 | ||
| Accumulated deficit | -2,875,833 | -2,063,149 | ||
| Total stockholders' (deficit) equity | -2,225,487 | -1,505,700 | ||
| Total liabilities and stockholders' equity | 176,237 | 205,371 | ||
Vor Biopharma Inc. (VOR)
Vor Biopharma Inc. (VOR)